CBS 2019
CBSMD教育中心
中 文

肺动脉高压

Abstract

Recommended Article

Bridging the Gap Between Epigenetic and Genetic in PAH Pulmonary Hypertension Caused by a Coconut Left Atrium Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension Left main coronary artery compression in pulmonary hypertension Updated clinical classification of pulmonary hypertension Risk Stratification in PAH Pulmonary Artery Denervation: An Alternative Therapy for Pulmonary Hypertension Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease

Guideline2016 Jan 1;37(1):67-119.

JOURNAL:Eur Heart J. Article Link

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)

Galiè N, Humbert M, ESC Scientific Document Group. Keywords: Chronic thromboembolic pulmonary hypertension; Congenital heart disease; Connective tissue disease; Endothelin receptor antagonists; Guidelines; Heart failure; Left heart disease; Lung disease; Phosphodiesterase type 5 inhibitors; Prostacyclin analogues; Pulmonary arterial hypertension; Pulmonary hypertension; Respiratory failure

FULL TEXT PDF